Hong Kong
· Delayed Price · Currency is HKD Shanghai Henlius Biotech Statistics
Total Valuation
HKG:2696 has a market cap or net worth of HKD 26.90 billion. The enterprise value is 29.92 billion.
| Market Cap | 26.90B |
| Enterprise Value | 29.92B |
Important Dates
The next estimated earnings date is Monday, August 18, 2025.
| Earnings Date | Aug 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2696 has 543.49 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 163.43M |
| Shares Outstanding | 543.49M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 6.19% |
| Float | 84.16M |
Valuation Ratios
The trailing PE ratio is 30.81 and the forward PE ratio is 29.62.
| PE Ratio | 30.81 |
| Forward PE | 29.62 |
| PS Ratio | 4.42 |
| PB Ratio | 8.39 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 23.45 |
| P/OCF Ratio | 20.36 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.79, with an EV/FCF ratio of 26.08.
| EV / Earnings | 34.27 |
| EV / Sales | 4.91 |
| EV / EBITDA | 22.79 |
| EV / EBIT | 32.45 |
| EV / FCF | 26.08 |
Financial Position
The company has a current ratio of 0.50, with a Debt / Equity ratio of 1.21.
| Current Ratio | 0.50 |
| Quick Ratio | 0.34 |
| Debt / Equity | 1.21 |
| Debt / EBITDA | 2.96 |
| Debt / FCF | 3.38 |
| Interest Coverage | 7.05 |
Financial Efficiency
Return on equity (ROE) is 31.52% and return on invested capital (ROIC) is 8.37%.
| Return on Equity (ROE) | 31.52% |
| Return on Assets (ROA) | 5.28% |
| Return on Invested Capital (ROIC) | 8.37% |
| Return on Capital Employed (ROCE) | 15.57% |
| Revenue Per Employee | 1.73M |
| Profits Per Employee | 248,399 |
| Employee Count | 3,515 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 2.07 |
Taxes
In the past 12 months, HKG:2696 has paid 27.04 million in taxes.
| Income Tax | 27.04M |
| Effective Tax Rate | 3.00% |
Stock Price Statistics
The stock price has increased by +122.35% in the last 52 weeks. The beta is 0.82, so HKG:2696's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +122.35% |
| 50-Day Moving Average | 42.73 |
| 200-Day Moving Average | 28.37 |
| Relative Strength Index (RSI) | 61.72 |
| Average Volume (20 Days) | 1,524,083 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2696 had revenue of HKD 6.09 billion and earned 873.12 million in profits. Earnings per share was 1.61.
| Revenue | 6.09B |
| Gross Profit | 4.45B |
| Operating Income | 922.11M |
| Pretax Income | 900.16M |
| Net Income | 873.12M |
| EBITDA | 1.24B |
| EBIT | 922.11M |
| Earnings Per Share (EPS) | 1.61 |
Balance Sheet
The company has 865.95 million in cash and 3.88 billion in debt, giving a net cash position of -3.02 billion or -5.55 per share.
| Cash & Cash Equivalents | 865.95M |
| Total Debt | 3.88B |
| Net Cash | -3.02B |
| Net Cash Per Share | -5.55 |
| Equity (Book Value) | 3.21B |
| Book Value Per Share | 5.90 |
| Working Capital | -2.68B |
Cash Flow
In the last 12 months, operating cash flow was 1.32 billion and capital expenditures -174.53 million, giving a free cash flow of 1.15 billion.
| Operating Cash Flow | 1.32B |
| Capital Expenditures | -174.53M |
| Free Cash Flow | 1.15B |
| FCF Per Share | 2.11 |
Margins
Gross margin is 73.10%, with operating and profit margins of 15.14% and 14.33%.
| Gross Margin | 73.10% |
| Operating Margin | 15.14% |
| Pretax Margin | 14.78% |
| Profit Margin | 14.33% |
| EBITDA Margin | 20.30% |
| EBIT Margin | 15.14% |
| FCF Margin | 18.83% |
Dividends & Yields
HKG:2696 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | n/a |
| Earnings Yield | 3.25% |
| FCF Yield | 4.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2696 has an Altman Z-Score of 0.87 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.87 |
| Piotroski F-Score | 6 |